-
Something wrong with this record ?
Use of micropulse laser in patients with diabetic macular edema at the department of ophthalmology, university hospital Hradec Králové
Veselá Š., Hejsek L., Stepanov A., Dusová J., Marák J., Jirásková N., Studnička J.
Language English Country Czech Republic
Document type Case Reports
- Keywords
- centrální retinální tloušťka, mikropulzní laser, zisk písmen,
- MeSH
- Radiation Dosage MeSH
- Diabetes Mellitus, Type 1 complications MeSH
- Diabetes Mellitus, Type 2 complications MeSH
- Diabetic Retinopathy diagnostic imaging complications MeSH
- Fundus Oculi MeSH
- Glycated Hemoglobin analysis MeSH
- Diabetes Complications * MeSH
- Laser Coagulation methods instrumentation MeSH
- Laser Therapy * methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Macular Edema * diagnostic imaging etiology therapy MeSH
- Tomography, Optical Coherence methods MeSH
- Retina diagnostic imaging MeSH
- Retrospective Studies MeSH
- Statistics as Topic MeSH
- Treatment Outcome MeSH
- Visual Acuity radiation effects MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Case Reports MeSH
Introduction: Diabetic macular edema (DME) is the most frequent cause of decreased vision in patiens with diabetes type 2. DME is caused by increased permeability of macular capillaries. The aim of our study was to retrospectively evaluate the results of micropulse laser treatment, 577 nm wavelength, in pacients with DME with follow-up three months and one year. Methods: The retrospective trial with one year follow-up includes 63 eyes of 37 patients with diabetic macular edema treated from September 2015 to January 2017. Most patients had diabetes type 2 (34 patients), 3 patients had diabetes type 1. Diffuse DME was diagnosed in 54 eyes, focal DME in 9 eyes. Most of the patients (42 eyes) suffered from non proliferative diabetic retinopathy, 21 eyes showed signs of proliferative retinopathy. DME lasted on average for 29 months before initiating with micropulse laser (median 21 months). On average 1,56 laser visits were needed for the treatment of 1 eye, usually in 3 months interval. Photocoagulation of macula was performed in all patients by micropulse laser, 577 nm wavelenght/IQ 577TM IRIDEX). We used 5 % duty cycle. The average glycated hemoglobin in the group was 66,8 mmol/mol, maximal 100 mmol/mol. Estimated data were statistically evaluated by Friedman and Dunn´s test. Results: At the end of 1 year period we found out improvement in BCVA (increase of at least 5 letters of ETDRS charts) in 20 eyes, 25 eyes showed stabilisation of BCVA (alltogether 71 % of the group), in 18 eyes we found out decrease of BCVA of more than 5 letters of ETDRS charts. On average we estimated decrease of visual acuity from 62 to 61,1 letters (p > 0,05). After one year we estimated 63 μm CRT decrease on average, from 442 μm to 379 μm (p= 0,0124). Conclusion: In our group of DME patiens treated by micropulse laser we have estimated BCVA stabilisation and signifiant improvement of macular edema in ¾ eyes, confirmed by OCT. We have estimated clinically significant decrease of macular edema in the whole group with one-year follow-up.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000073
- 003
- CZ-PrNML
- 005
- 20210602022144.0
- 007
- cr|cn|
- 008
- 190104s2018 xr ac fs 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.31348/2018/1/2-2-2018 $2 doi
- 035 __
- $a (PubMed)30441950
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Veselá, Šárka $7 xx0228406 $u Department of Ophthalmology, University Hospital Hradec Králové
- 245 10
- $a Use of micropulse laser in patients with diabetic macular edema at the department of ophthalmology, university hospital Hradec Králové / $c Veselá Š., Hejsek L., Stepanov A., Dusová J., Marák J., Jirásková N., Studnička J.
- 520 3_
- $a Introduction: Diabetic macular edema (DME) is the most frequent cause of decreased vision in patiens with diabetes type 2. DME is caused by increased permeability of macular capillaries. The aim of our study was to retrospectively evaluate the results of micropulse laser treatment, 577 nm wavelength, in pacients with DME with follow-up three months and one year. Methods: The retrospective trial with one year follow-up includes 63 eyes of 37 patients with diabetic macular edema treated from September 2015 to January 2017. Most patients had diabetes type 2 (34 patients), 3 patients had diabetes type 1. Diffuse DME was diagnosed in 54 eyes, focal DME in 9 eyes. Most of the patients (42 eyes) suffered from non proliferative diabetic retinopathy, 21 eyes showed signs of proliferative retinopathy. DME lasted on average for 29 months before initiating with micropulse laser (median 21 months). On average 1,56 laser visits were needed for the treatment of 1 eye, usually in 3 months interval. Photocoagulation of macula was performed in all patients by micropulse laser, 577 nm wavelenght/IQ 577TM IRIDEX). We used 5 % duty cycle. The average glycated hemoglobin in the group was 66,8 mmol/mol, maximal 100 mmol/mol. Estimated data were statistically evaluated by Friedman and Dunn´s test. Results: At the end of 1 year period we found out improvement in BCVA (increase of at least 5 letters of ETDRS charts) in 20 eyes, 25 eyes showed stabilisation of BCVA (alltogether 71 % of the group), in 18 eyes we found out decrease of BCVA of more than 5 letters of ETDRS charts. On average we estimated decrease of visual acuity from 62 to 61,1 letters (p > 0,05). After one year we estimated 63 μm CRT decrease on average, from 442 μm to 379 μm (p= 0,0124). Conclusion: In our group of DME patiens treated by micropulse laser we have estimated BCVA stabilisation and signifiant improvement of macular edema in ¾ eyes, confirmed by OCT. We have estimated clinically significant decrease of macular edema in the whole group with one-year follow-up.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a výsledek terapie $7 D016896
- 650 12
- $a komplikace diabetu $7 D048909
- 650 _2
- $a diabetes mellitus 2. typu $x komplikace $7 D003924
- 650 _2
- $a diabetes mellitus 1. typu $x komplikace $7 D003922
- 650 12
- $a makulární edém $x diagnostické zobrazování $x etiologie $x terapie $7 D008269
- 650 12
- $a laserová terapie $x metody $7 D053685
- 650 _2
- $a optická koherentní tomografie $x metody $7 D041623
- 650 _2
- $a laserová koagulace $x metody $x přístrojové vybavení $7 D017075
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a diabetická retinopatie $x diagnostické zobrazování $x komplikace $7 D003930
- 650 _2
- $a glykovaný hemoglobin $x analýza $7 D006442
- 650 _2
- $a statistika jako téma $7 D013223
- 650 _2
- $a zraková ostrost $x účinky záření $7 D014792
- 650 _2
- $a retina $x diagnostické zobrazování $7 D012160
- 650 _2
- $a fundus oculi $7 D005654
- 650 _2
- $a dávka záření $7 D011829
- 653 00
- $a centrální retinální tloušťka
- 653 00
- $a mikropulzní laser
- 653 00
- $a zisk písmen
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Hejsek, Libor, $d 1977- $7 mzk2007408327 $u Department of Ophthalmology, University Hospital Hradec Králové
- 700 1_
- $a Stěpanov, Alexandr $u Department of Ophthalmology, University Hospital Hradec Králové $7 xx0227507
- 700 1_
- $a Dusová, Jaroslava, $u Department of Ophthalmology, University Hospital Hradec Králové $d 1959- $7 xx0063648
- 700 1_
- $a Marák, Jan $u Department of Ophthalmology, University Hospital Hradec Králové $7 xx0159941
- 700 1_
- $a Jirásková, Naďa, $u Department of Ophthalmology, University Hospital Hradec Králové $d 1965- $7 mzk2007395044
- 700 1_
- $a Studnička, Jan $u Department of Ophthalmology, University Hospital Hradec Králové $7 jx20090420023
- 773 0_
- $t Czech and Slovak Ophthalmology $g Roč. 5, č. 2 (2018), s. 53-58 $w MED00194413
- 856 41
- $u http://www.cs-ophthalmology.cz/en/journal/2018/2/2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $y p $z 0
- 990 __
- $a 20190104132740 $b ABA008
- 991 __
- $a 20210602022143 $b ABA008
- 999 __
- $a ok $b bmc $g 1363066 $s 1038185
- BAS __
- $a 3 $a 4
- BMC __
- $a 2018 $b 5 $c 2 $d 53-58 $m Czech and Slovak Ophthalmology $x MED00194413
- LZP __
- $c NLK189 $d 20210531 $a NLK 2019-01/pk